Literature DB >> 31999638

Invasive fungal rhinosinusitis in patients with diabetes.

Nishant Raizada1, Viveka P Jyotsna2, Devasenathipathy Kandasamy3, Immaculata Xess4, Alok Thakar5, Nikhil Tandon6.   

Abstract

INTRODUCTION: We report the clinical and radiological features as well as outcomes of invasive fungal rhinosinusitis in patients with diabetes from a tertiary care center in North India.
METHODOLOGY: All patients admitted with a diagnosis of invasive fungal rhinosinusitis with pre-existing or newly diagnosed diabetes from 1st January 2008 to 31st December 2015 were included. Hospital records were used to identify clinical features, biochemical investigations and treatment modalities used. The imaging findings were reported at baseline, 30, 60,90 and 120 days of admission and progression of disease was reported as static, worse or improved. The outcomes were sight loss and survival at end of hospital stay.
RESULTS: 22 patients of invasive fungal sinusitis and diabetes were identified. At presentation, 5 had ketoacidosis, all of whom died at the end of hospital stay. Loss of vision in one eye was seen in 70% cases. The survival at end of hospital stay was 72.7% and at six months after end of study period was 57.8%. No patients had radiological improvement at day 30 imaging (including those who subsequently improved).
CONCLUSION: Radiological improvement is not apparent before two months of therapy. Ketoacidosis is a predictor of mortality in invasive fungal sinusitis with diabetes. Copyright (c) 2018 Nishant Raizada, Viveka P Jyotsna, Devasenathipathy Kandasamy, Immaculata Xess, Alok Thakar, Nikhil Tandon.

Entities:  

Keywords:  diabetes; invasive fungal rhinosinusitis; liposomal amphotericin B; mucormycosis

Mesh:

Substances:

Year:  2018        PMID: 31999638     DOI: 10.3855/jidc.9699

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  1 in total

1.  Prognostication of Sino-Nasal Mucormycosis.

Authors:  Prem Sagar; Namrita Mehmi; Anupam Kanodia; Avinash Shekhar Jaiswal; Rajeev Kumar; Chirom Amit Singh; Rakesh Kumar; Alok Thakar
Journal:  Iran J Otorhinolaryngol       Date:  2022-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.